Showing 1 - 7 results of 7 for search 'Stefan O. Mueller', query time: 0.04s Refine Results
  1. 1
    mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents

    mRNA-based SARS-CoV-2 vaccine candidate CVnCoV induces high levels of virus-neutralising antibodies and mediates protection in rodents by Susanne Rauch, Nicole Roth, Kim Schwendt, Mariola Fotin-Mleczek, Stefan O. Mueller, Benjamin Petsch

    Published 2021-04-01
    Get full text
    Article
  2. 2
    Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses

    Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses by Nicole Roth, Jacob Schön, Donata Hoffmann, Moritz Thran, Andreas Thess, Stefan O. Mueller, Benjamin Petsch, Susanne Rauch

    Published 2022-08-01
    Get full text
    Article
  3. 3
    mRNA vaccines induce rapid antibody responses in mice

    mRNA vaccines induce rapid antibody responses in mice by Makda S. Gebre, Susanne Rauch, Nicole Roth, Janina Gergen, Jingyou Yu, Xiaowen Liu, Andrew C. Cole, Stefan O. Mueller, Benjamin Petsch, Dan H. Barouch

    Published 2022-08-01
    Get full text
    Article
  4. 4
    A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses

    A third dose of the unmodified COVID-19 mRNA vaccine CVnCoV enhances quality and quantity of immune responses by Klara Lenart, Fredrika Hellgren, Sebastian Ols, Xianglei Yan, Alberto Cagigi, Rodrigo Arcoverde Cerveira, Inga Winge, Jakub Hanczak, Stefan O. Mueller, Edith Jasny, Kim Schwendt, Susanne Rauch, Benjamin Petsch, Karin Loré

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models

    Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models by Nicole Roth, Janina Gergen, Kristina Kovacikova, Stefan O. Mueller, Lorenz Ulrich, Jacob Schön, Nico Joel Halwe, Charlie Fricke, Björn Corleis, Anca Dorhoi, Donata Hoffmann, Martin Beer, Domenico Maione, Benjamin Petsch, Susanne Rauch

    Published 2023-01-01
    Get full text
    Article
  6. 6
    Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models

    Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models by Björn Corleis, Donata Hoffmann, Susanne Rauch, Charlie Fricke, Nicole Roth, Janina Gergen, Kristina Kovacikova, Kore Schlottau, Nico Joel Halwe, Lorenz Ulrich, Jacob Schön, Kerstin Wernike, Marek Widera, Sandra Ciesek, Stefan O. Mueller, Thomas C. Mettenleiter, Domenico Maione, Benjamin Petsch, Martin Beer, Anca Dorhoi

    Published 2023-02-01
    Get full text
    Article
  7. 7
    CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

    CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2 by Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, Lorenz Ulrich, Charlie Fricke, Jacob Schön, Anna Kraft, Angele Breithaupt, Kerstin Wernike, Anna Michelitsch, Franziska Sick, Claudia Wylezich, Bernd Hoffmann, Moritz Thran, Andreas Thess, Stefan O. Mueller, Thomas C. Mettenleiter, Benjamin Petsch, Anca Dorhoi, Martin Beer

    Published 2021-06-01
    Get full text
    Article

Search Tools: